Browsing by Sponsor/Funder Univ of Sydney (original funder Amgen Inc)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
27-Aug-2019Correction: Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial (vol 73, pg 2961, 2019)Charytan, DM; Sabatine, MS; Pedersen, TR; Park, J-G; Pineda, AL, et al
Aug-2021LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.Sever, P; Gouni-Berthold, I; Keech, A; Giugliano, R; Pedersen, TR, et al